USFDA nod to Leqembi IV maintenance dosing for treatment of early Alzheimer's Disease: Eisai, Biogen Ruchika Sharma27 Jan 2025 12:22 PM ISTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental...
Sage Therapeutics reshuffles leadership, cuts 165 jobs to focus on postpartum depression drug launch MD Bureau19 Oct 2024 10:30 AM ISTThe drugmaker plans to prioritize the launch of its postpartum depression pill Zurzuvae, that has been jointly developed with Biogen.
Eli Lilly appoints Melissa Seymour as executive vice president of Global Quality Ruchika Sharma5 Jun 2024 11:30 AM ISTIndianapolis: Eli Lilly and Company has announced that Melissa Seymour will join the company as executive vice president of Global Quality and member...
EU medicines regulator backs Biogen ALS drug Ruchika Sharma25 Feb 2024 11:30 AM ISTCambridge: Biogen Inc. has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a...
USFDA approvals bounce back in 2023, sparking hopes of biotech recovery Ruchika Sharma3 Jan 2024 3:22 PM ISTThe U.S. Food and Drug Administration approved nearly 50% more novel drugs in 2023 than in 2022, putting it back on pace with historical levels, an...
Roche settles patent lawsuit against Biogen over biosimilar version of rheumatoid arthritis drug Actemra Ruchika Sharma26 Oct 2023 1:30 PM ISTBasel: Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of...
Biogen, Eisai get Japanese nod for Leqembi Intravenous Infusion for Alzheimer's Disease Ruchika Sharma25 Sept 2023 12:30 PM ISTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody LEQEMBI...
Dr Reddy's Labs appoints Dr Alpna Hansraj Seth as Independent Additional Director Ruchika Sharma20 Sept 2023 12:38 PM ISTTelangana: Dr Reddy's Labs has announced the appointment of Dr. Alpna Hansraj Seth as an Additional Director, categorized as Independent, on the Board...
New postpartum depression pill could be game changer Roshni Dhar17 Aug 2023 5:03 PM ISTThe U.S. Food and Drug Administration has approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in...
Biogen, Sage Therapeutics get USFDA nod for Zurzuvae for postpartum depression in women Ruchika Sharma6 Aug 2023 3:30 PM ISTCambridge: Biogen Inc. and Sage Therapeutics, Inc. have announced the U.S. Food and Drug Administration (FDA) has approved ZURZUVAE (zuranolone)...
Eisai seeks marketing nod for Lecanemab for early Alzheimer's disease treatment in South Korea Ruchika Sharma11 Jun 2023 12:45 PM ISTLecanemab is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of...
USFDA advisory committee votes unanimously to confirm clinical benefit of Leqembi for Alzheimer's Disease Ruchika Sharma10 Jun 2023 1:30 PM ISTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System...
